Skip to main content

Abcellera Biologics Inc(ABCL-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low7.48
Day High7.65
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Press & news

Latest News

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
Business Wire - Wed Mar 22, 8:00AM CDT
Business Wire
Wed Mar 22, 8:00AM CDT
AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify optimal clinical candidates for up to three infectious disease targets selected by RQ Bio, including influenza and...
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
Business Wire - Tue Mar 14, 3:30PM CDT
Business Wire
Tue Mar 14, 3:30PM CDT
AbCellera (Nasdaq: ABCL) today announced two upcoming poster presentations on its T-cell engager platform at the American Association for Cancer Research (AACR) Annual Meeting 2023, to be held at the Orange County Convention Center in Orlando,...
Tuesday’s analyst upgrades and downgrades
The Globe and Mail - Tue Feb 28, 6:00AM CST
The Globe and Mail
Tue Feb 28, 6:00AM CST
Inside the Market’s roundup of some of today’s key analyst actions

Latest Articles